Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
PMC 6611390
Wound Repair & Angiogenesis Rodent wound models have reported accelerated re-epithelialization and increased capillary density in GHK-Cu-treated cohorts, with mechanistic work pointing to fibroblast recruitment, immune cell signaling, and pro-angiogenic gene expression
The in silico ADMET profiles for the top-ranked hits were predicted and the predicted non-toxic lead molecules showed the highest docking score in the range of 12.72 kcal/mol to 11.97 kcal/mol
Phase 2 MASH trial doses: 2.4 mg, 4.8 mg, and 6.0 mg once weekly with a 24-week rapid dose-escalation phase followed by a 24-week maintenance phase
Common local reactions may include mild pain, redness, or swelling at the injection site
If choosing NAC, look for a pure, third-party tested source
US$ 27.61
US$ 27.78
US$ 28.31
US$ 24.44
US$ 25.82
US$ 25.72
US$ 23.10
US$ 26.09
US$ 28.27
US$ 22.14
US$ 21.52
.jpg)
